IL5 and eosinophilic granulomatosis with polyangiitis: Taken together, these studies revealed that ILC2-derived IL-5, rather than Th2-derived IL-5, plays an essential role in eosinophil tissue damage and that ILC2s could be a potential therapeutic target for EGPA.